🇺🇸 FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11993638

GM-CSF mimetics and methods of making and using same

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11795216

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as anal

Takeda Pharmaceutical Company Limited · Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11267859

GM-CSF mimetics and methods of making and using same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11173208

Liquid formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11078264

Inhibiting granulocyte macrophage-colony stimulating factor (GM-CSF) prevents preterm birt

UNIVERSITY OF CONNECTICUT · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10758621

Liquid formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10745475

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as anal

TAKEDA GMBH · Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919051

Liquid formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833410

Lyophilized formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6809191

GM-CSF nucleic acid sequences

Vaxim, Inc. · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6326198

Methods and compositions for the ex vivo replication of stem cells, for the optimization o

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired